National Research Corporation Elevates Leadership Team to Seize Growth Opportunity
17 Gennaio 2024 - 9:00PM
Business Wire
National Research Corporation, dba NRC Health, (NASDAQ:NRC) has
announced the following appointments of four newly created
executive officer positions:
- Helen Hrdy – Chief Customer Officer
- Jason Hahn – Chief Revenue Officer
- Christophe Louvion – Chief Product Technology Officer
- Andy Monnich – Chief Corporate Development Officer
Helen Hrdy, a leader at NRC Health, has been promoted to the
role of Chief Customer Officer significantly expanding her
responsibilities. Jason Hahn, Christophe Louvion, and Andy Monnich
have joined NRC Health with a track record of success in similar
positions at leading healthcare information and technology
companies such as Press Ganey, Perceptyx, Episource, PatientPop,
and Practicing Excellence.
Chief Executive Officer Michael Hays emphasizes, “This
announcement reflects one of several investments to capture
expanding market opportunities through serving clients across
increasingly interconnected patient, customer, and employee
experience markets, which collectively have the potential to double
the Company's total addressable market. In fact, we recently won a
significant multi-million-dollar contract with Advocate Health, the
fifth largest not-for-profit health system in the country. This win
underscores the competitive advantage gained through an expanded
product portfolio built on a strong foundation of healthcare
expertise. With the guidance of our expanded leadership team, NRC
Health is focused on fully capitalizing on these
opportunities.”
For more than 40 years, NRC Health has led the charge to
humanize healthcare and support organizations in their
understanding of each unique individual. NRC Health’s commitment to
Human Understanding® helps leading healthcare systems get to know
each person they serve not as point-in-time insights, but as an
ongoing relationship. Guided by its uniquely empathic heritage, NRC
Health’s patient-focused approach, unmatched market research, and
emphasis on consumer preferences are transforming the healthcare
experience, creating strong outcomes for patients and entire
healthcare systems. For more information, email info@nrchealth.com,
or visit www.nrchealth.com.
This press release contains certain statements that may be
considered forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended, and such
statements are subject to the safe harbor created by those sections
and the Private Securities Litigation Reform Act of 1995, as
amended. Such statements may be identified by their use of terms or
phrases such as “believes,” “expect,” “focus,” “potential,” “will,”
derivations thereof, and similar terms and phrases. In this press
release, the statement related to the potential to double the
Company’s total addressable market is a forward-looking statement.
Forward-looking statements are based upon the current beliefs and
expectations of our management and are inherently subject to risks
and uncertainties, some of which cannot be predicted or quantified,
which could cause future events and actual results to differ
materially from those set forth in, contemplated by, or underlying
the forward-looking statements, including those risks and
uncertainties as set forth in the Risk Factors section of our
Annual Report on Form 10-K for the year ended December 31, 2022 and
various disclosures in our press releases, stockholder reports, and
other filings with the Securities and Exchange Commission. We
disclaim any obligation to update or revise any forward-looking
statements to reflect actual results or changes in the factors
affecting the forward-looking information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240117727879/en/
Kevin R. Karas Chief Financial Officer
402-475-2525
Grafico Azioni National Research (NASDAQ:NRC)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni National Research (NASDAQ:NRC)
Storico
Da Giu 2023 a Giu 2024